Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +3.28% | +2.44% | -16.56% |
Financials (USD)
Sales 2024 * | 745M | Sales 2025 * | 796M | Capitalization | 878M |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -185M | EV / Sales 2024 * | 1.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
-3.45
x | P/E ratio 2025 * |
-4.91
x | Employees | 3,930 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.01% |
Latest transcript on OPKO Health, Inc.
1 day | +3.28% | ||
1 week | +2.44% | ||
Current month | +5.00% | ||
1 month | +24.75% | ||
3 months | +27.97% | ||
Current year | -16.56% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Adam Logal
DFI | Director of Finance/CFO | 46 | 07-02-28 |
Elias Zerhouni
PSD | President | 72 | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
CEO | Chief Executive Officer | 87 | 07-03-26 |
Roger Medel
BRD | Director/Board Member | 77 | 20-12-17 |
Director/Board Member | 68 | 07-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.07% | 509 M€ | -.--% | ||
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.26 | +3.28% | 1,947,676 |
24-04-25 | 1.22 | -0.81% | 4,751,377 |
24-04-24 | 1.23 | -1.60% | 6,063,826 |
24-04-23 | 1.25 | +1.63% | 2,387,338 |
24-04-22 | 1.23 | 0.00% | 3,627,063 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.56% | 878M | |
-17.89% | 8.25B | |
+39.20% | 3.57B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- OPK Stock